These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

375 related items for PubMed ID: 25772644

  • 21. Eradication of multidrug-resistant Acinetobacter baumannii from the respiratory tract with inhaled colistin methanesulfonate: a matched case-control study.
    Kuo SC, Lee YT, Yang SP, Chen CP, Chen TL, Hsieh SL, Siu LK, Fung CP.
    Clin Microbiol Infect; 2012 Sep; 18(9):870-6. PubMed ID: 21999321
    [Abstract] [Full Text] [Related]

  • 22. Early administration of appropriate antimicrobial agents to improve the outcome of carbapenem-resistant Acinetobacter baumannii complex bacteraemic pneumonia.
    Park SY, Lee EJ, Kim T, Yu SN, Park KH, Lee MS, Park SY, Jeon MH, Kim TH, Choo EJ.
    Int J Antimicrob Agents; 2018 Mar; 51(3):407-412. PubMed ID: 29122697
    [Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24. Comparable Efficacy of Tigecycline versus Colistin Therapy for Multidrug-Resistant and Extensively Drug-Resistant Acinetobacter baumannii Pneumonia in Critically Ill Patients.
    Kim WY, Moon JY, Huh JW, Choi SH, Lim CM, Koh Y, Chong YP, Hong SB.
    PLoS One; 2016 Mar; 11(3):e0150642. PubMed ID: 26934182
    [Abstract] [Full Text] [Related]

  • 25. Intravenous and inhalational colistin-induced respiratory failure.
    Wahby K, Chopra T, Chandrasekar P.
    Clin Infect Dis; 2010 Mar 15; 50(6):e38-40. PubMed ID: 20146630
    [Abstract] [Full Text] [Related]

  • 26. Treatment of Carbapenem-Resistant Acinetobacter baumannii Ventilator-Associated Pneumonia: Retrospective Comparison Between Intravenous Colistin and Intravenous Ampicillin-Sulbactam.
    Zalts R, Neuberger A, Hussein K, Raz-Pasteur A, Geffen Y, Mashiach T, Finkelstein R.
    Am J Ther; 2016 Mar 15; 23(1):e78-85. PubMed ID: 24263165
    [Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29. Efficacy of high-dose nebulized colistin in ventilator-associated pneumonia caused by multidrug-resistant Pseudomonas aeruginosa and Acinetobacter baumannii.
    Lu Q, Luo R, Bodin L, Yang J, Zahr N, Aubry A, Golmard JL, Rouby JJ, Nebulized Antibiotics Study Group.
    Anesthesiology; 2012 Dec 15; 117(6):1335-47. PubMed ID: 23132092
    [Abstract] [Full Text] [Related]

  • 30. Use of adjunctive aerosolized antimicrobial therapy in the treatment of Pseudomonas aeruginosa and Acinetobacter baumannii ventilator-associated pneumonia.
    Arnold HM, Sawyer AM, Kollef MH.
    Respir Care; 2012 Aug 15; 57(8):1226-33. PubMed ID: 22349038
    [Abstract] [Full Text] [Related]

  • 31. Incidence and Risk Factors for Colistin-Associated Nephrotoxicity.
    Temocin F, Erdinc S, Tulek N, Demirelli M, Bulut C, Ertem G.
    Jpn J Infect Dis; 2015 Aug 15; 68(4):318-20. PubMed ID: 25720641
    [Abstract] [Full Text] [Related]

  • 32. Inhaled colistin as monotherapy for multidrug-resistant gram (-) nosocomial pneumonia: a case series.
    Falagas ME, Siempos II, Rafailidis PI, Korbila IP, Ioannidou E, Michalopoulos A.
    Respir Med; 2009 May 15; 103(5):707-13. PubMed ID: 19118994
    [Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36. Colistin and rifampicin in the treatment of multidrug-resistant Acinetobacter baumannii infections.
    Bassetti M, Repetto E, Righi E, Boni S, Diverio M, Molinari MP, Mussap M, Artioli S, Ansaldi F, Durando P, Orengo G, Bobbio Pallavicini F, Viscoli C.
    J Antimicrob Chemother; 2008 Feb 15; 61(2):417-20. PubMed ID: 18174197
    [Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38. Randomized controlled trial of nebulized colistimethate sodium as adjunctive therapy of ventilator-associated pneumonia caused by Gram-negative bacteria.
    Rattanaumpawan P, Lorsutthitham J, Ungprasert P, Angkasekwinai N, Thamlikitkul V.
    J Antimicrob Chemother; 2010 Dec 15; 65(12):2645-9. PubMed ID: 20876621
    [Abstract] [Full Text] [Related]

  • 39. Exposure to quinolones is associated with carbapenem resistance among colistin-susceptible Acinetobacter baumannii blood isolates.
    Kopterides P, Koletsi PK, Michalopoulos A, Falagas ME.
    Int J Antimicrob Agents; 2007 Nov 15; 30(5):409-14. PubMed ID: 17851052
    [Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 19.